These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

962 related items for PubMed ID: 10908087

  • 1. Plasma amino-terminal pro-brain natriuretic peptide: a novel approach to the diagnosis of cardiac dysfunction.
    Campbell DJ, Mitchelhill KI, Schlicht SM, Booth RJ.
    J Card Fail; 2000 Jun; 6(2):130-9. PubMed ID: 10908087
    [Abstract] [Full Text] [Related]

  • 2. Renal and cardiac function for long-term (10 year) risk stratification after myocardial infarction.
    Palmer SC, Yandle TG, Frampton CM, Troughton RW, Nicholls MG, Richards AM.
    Eur Heart J; 2009 Jun; 30(12):1486-94. PubMed ID: 19389787
    [Abstract] [Full Text] [Related]

  • 3. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M, Bozkurt A, Yildiray-Sahin D, Unal I, Acartürk E.
    Cardiol J; 2009 Jun; 16(1):43-9. PubMed ID: 19130415
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease.
    Hess G, Runkel S, Zdunek D, Hitzler WE.
    Clin Lab; 2005 Jun; 51(3-4):167-72. PubMed ID: 15819172
    [Abstract] [Full Text] [Related]

  • 6. Comparative value of BNP and NT-proBNP in diagnosis of heart failure.
    Fonseca C, Sarmento PM, Minez A, Gonçalves E, Covas R, Dias AR, Pina MJ, Ceia F.
    Rev Port Cardiol; 2004 Jun; 23(7-8):979-91. PubMed ID: 15478324
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
    David S, Kümpers P, Seidler V, Biertz F, Haller H, Fliser D.
    Nephrol Dial Transplant; 2008 Apr; 23(4):1370-7. PubMed ID: 18089624
    [Abstract] [Full Text] [Related]

  • 10. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D, Matias JS, Sargento L, Cabral MJ, Madeira HC.
    Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
    [Abstract] [Full Text] [Related]

  • 11. The acute effect of Metoprolol upon NT-proBNP level in patients with congestive heart failure.
    Zdrenghea D, Pop D, Ilea M, Bodisz G, Mălai A, Zdrenghea M.
    Rom J Intern Med; 2009 Dec; 47(1):35-40. PubMed ID: 19886067
    [Abstract] [Full Text] [Related]

  • 12. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
    Kallistratos MS, Dritsas A, Laoutaris ID, Cokkinos DV.
    J Heart Lung Transplant; 2007 May; 26(5):516-21. PubMed ID: 17449423
    [Abstract] [Full Text] [Related]

  • 13. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction.
    Richards AM, Nicholls MG, Espiner EA, Lainchbury JG, Troughton RW, Elliott J, Frampton C, Turner J, Crozier IG, Yandle TG.
    Circulation; 2003 Jun 10; 107(22):2786-92. PubMed ID: 12771003
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. NT-proBNP levels in the evaluation of right ventricular dysfunction in patients with coronary artery disease and abnormal left ventricular wall motion: a magnetic resonance imaging study.
    Krittayaphong R, Boonyasirinant T, Saiviroonporn P, Udompunturak S.
    Coron Artery Dis; 2008 Nov 10; 19(7):481-7. PubMed ID: 18923244
    [Abstract] [Full Text] [Related]

  • 16. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases.
    Sirithunyanont C, Leowattana W, Sukumalchantra Y, Chaisupamonkollarp S, Watanawaroon S, Chivatanaporn B, Bhuripanyo K, Mahanonda N.
    J Med Assoc Thai; 2003 May 10; 86 Suppl 1():S87-95. PubMed ID: 12866774
    [Abstract] [Full Text] [Related]

  • 17. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
    Anwaruddin S, Lloyd-Jones DM, Baggish A, Chen A, Krauser D, Tung R, Chae C, Januzzi JL.
    J Am Coll Cardiol; 2006 Jan 03; 47(1):91-7. PubMed ID: 16386670
    [Abstract] [Full Text] [Related]

  • 18. B-type natriuretic peptide (BNP) and N-terminal-proBNP for heart failure diagnosis in shock or acute respiratory distress.
    Bal L, Thierry S, Brocas E, Van de Louw A, Pottecher J, Hours S, Moreau MH, Perrin Gachadoat D, Tenaillon A.
    Acta Anaesthesiol Scand; 2006 Mar 03; 50(3):340-7. PubMed ID: 16480468
    [Abstract] [Full Text] [Related]

  • 19. Head-to-head comparison of BNP and IL-6 as markers of clinical and experimental heart failure: Superiority of BNP.
    Birner CM, Ulucan C, Fredersdorf S, Rihm M, Löwel H, Stritzke J, Schunkert H, Hengstenberg C, Holmer S, Riegger G, Luchner A.
    Cytokine; 2007 Nov 03; 40(2):89-97. PubMed ID: 17920926
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.